Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 298.87 USD -0.43% Market Closed
Market Cap: 6.6B USD

Intrinsic Value

The intrinsic value of one MDGL stock under the Base Case scenario is 429.72 USD. Compared to the current market price of 298.87 USD, Madrigal Pharmaceuticals Inc is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDGL Intrinsic Value
429.72 USD
Undervaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Madrigal Pharmaceuticals Inc

Compare MDGL to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MDGL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Madrigal Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Madrigal Pharmaceuticals Inc

Current Assets 1.1B
Cash & Short-Term Investments 998.6m
Receivables 30.5m
Other Current Assets 34.6m
Non-Current Assets 9.6m
PP&E 4.8m
Intangibles 4.8m
Efficiency

Free Cash Flow Analysis
Madrigal Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Madrigal Pharmaceuticals Inc

Revenue
317.4m USD
Cost of Revenue
-10.7m USD
Gross Profit
306.6m USD
Operating Expenses
-731.8m USD
Operating Income
-425.1m USD
Other Expenses
33.6m USD
Net Income
-391.6m USD
Fundamental Scores

MDGL Profitability Score
Profitability Due Diligence

Madrigal Pharmaceuticals Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional Gross Margin
ROE is Increasing
Sustainable 3Y Average Gross Margin
36/100
Profitability
Score

Madrigal Pharmaceuticals Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

MDGL Solvency Score
Solvency Due Diligence

Madrigal Pharmaceuticals Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
86/100
Solvency
Score

Madrigal Pharmaceuticals Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast MDGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDGL is 430.37 USD with a low forecast of 250.48 USD and a high forecast of 567 USD.

Lowest
Price Target
250.48 USD
16% Downside
Average
Price Target
430.37 USD
44% Upside
Highest
Price Target
567 USD
90% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Madrigal Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MDGL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MDGL Insider Trading
Buy and sell transactions by insiders

MDGL News

Other Videos
What is the Intrinsic Value of one MDGL stock?

The intrinsic value of one MDGL stock under the Base Case scenario is 429.72 USD.

Is MDGL stock undervalued or overvalued?

Compared to the current market price of 298.87 USD, Madrigal Pharmaceuticals Inc is Undervalued by 30%.

Back to Top